Detalhe da pesquisa
1.
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
Mult Scler
; : 13524585241240653, 2024 Mar 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38551315
2.
Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina.
Neurol Sci
; 45(2): 379-389, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38159147
3.
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients.
Mult Scler
; 29(14): 1841-1848, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37728389
4.
Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina.
Neurol Sci
; 44(1): 281-286, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36166174
5.
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Mult Scler
; 28(7): 1138-1145, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35475363
6.
The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia.
Mult Scler
; 27(6): 913-921, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33565909
7.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3369-3371, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32918634
8.
Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 41(11): 3329-3335, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32840711
9.
Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS Registry (RelevarEM).
Neurol Sci
; 41(6): 1513-1519, 2020 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31960250
10.
Correction to: Clinical and demographic characteristics of primary progressive multiple sclerosis in Argentina: Argentinean registry cohort study (RelevarEM).
Neurol Sci
; 42(12): 5441, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34557969
11.
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab.
JAMA Netw Open
; 7(4): e246345, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38607624
12.
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Neurology
; 102(7): e209156, 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-38447105
13.
Liquid Biopsy in Neurological Diseases.
Cells
; 12(14)2023 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37508574
14.
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(1)2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36411079
15.
Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36973075
16.
Primary Central Nervous System Vasculitis Following Alemtuzumab Treatment for Multiple Sclerosis: A Case Report and Literature Review.
Neurologist
; 28(4): 270-272, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36728655
17.
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating Event.
Neurology
; 101(13): e1280-e1292, 2023 09 26.
Artigo
Inglês
| MEDLINE | ID: mdl-37468284
18.
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Mult Scler J Exp Transl Clin
; 9(1): 20552173231154712, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36846108
19.
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Mult Scler Relat Disord
; 79: 104935, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37634468
20.
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Mult Scler J Exp Transl Clin
; 9(4): 20552173231205444, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37854639